JP2012532894A - 抗インフルエンザ薬 - Google Patents

抗インフルエンザ薬 Download PDF

Info

Publication number
JP2012532894A
JP2012532894A JP2012519850A JP2012519850A JP2012532894A JP 2012532894 A JP2012532894 A JP 2012532894A JP 2012519850 A JP2012519850 A JP 2012519850A JP 2012519850 A JP2012519850 A JP 2012519850A JP 2012532894 A JP2012532894 A JP 2012532894A
Authority
JP
Japan
Prior art keywords
optionally substituted
acetamido
dideoxy
anhydro
glycero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012519850A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532894A5 (enExample
Inventor
イツスタイン，マーク フォン
クリフォード ダイアソン，ジェフリー
トムソン，ロビン
ルドラウォー，サントーシュ
パスコルッティ，マウロ
Original Assignee
グリフィス ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009903329A external-priority patent/AU2009903329A0/en
Application filed by グリフィス ユニバーシティ filed Critical グリフィス ユニバーシティ
Publication of JP2012532894A publication Critical patent/JP2012532894A/ja
Publication of JP2012532894A5 publication Critical patent/JP2012532894A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2012519850A 2009-07-16 2010-07-16 抗インフルエンザ薬 Pending JP2012532894A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009903329A AU2009903329A0 (en) 2009-07-16 Anti-influenza agents
AU2009903329 2009-07-16
PCT/AU2010/000905 WO2011006208A1 (en) 2009-07-16 2010-07-16 Anti -influenza agents

Publications (2)

Publication Number Publication Date
JP2012532894A true JP2012532894A (ja) 2012-12-20
JP2012532894A5 JP2012532894A5 (enExample) 2013-09-05

Family

ID=43448806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519850A Pending JP2012532894A (ja) 2009-07-16 2010-07-16 抗インフルエンザ薬

Country Status (11)

Country Link
US (1) US20120202877A1 (enExample)
EP (1) EP2454248A4 (enExample)
JP (1) JP2012532894A (enExample)
CN (1) CN102612514B (enExample)
AU (1) AU2010273184B2 (enExample)
CA (1) CA2768081A1 (enExample)
IL (1) IL217523A0 (enExample)
MX (1) MX2012000576A (enExample)
RU (1) RU2012105073A (enExample)
SG (1) SG177633A1 (enExample)
WO (1) WO2011006208A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015117233A (ja) * 2013-11-15 2015-06-25 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
JP2018016579A (ja) * 2016-07-27 2018-02-01 国立研究開発法人理化学研究所 シアル酸類縁体

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
EP2903430A1 (en) 2012-10-05 2015-08-12 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
US11773129B2 (en) 2017-05-25 2023-10-03 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
JP2022543006A (ja) * 2019-07-30 2022-10-07 グリフィス・ユニバーシティ 抗ウイルス剤およびその使用
US12116382B2 (en) 2022-11-28 2024-10-15 Hongene Biotech Corporation Functionalized N-acetylgalactosamine analogs

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507068A (ja) * 1990-04-24 1993-10-14 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ２―デオキシ―２，３―ジデヒドロ―ｎ―アセチルノイラミン酸の誘導体及び類似体と抗ウイルス剤としてのそれらの用途
WO1998011083A1 (en) * 1996-09-10 1998-03-19 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydrosialic acids
JPH11279168A (ja) * 1996-07-22 1999-10-12 Sankyo Co Ltd ノイラミン酸誘導体
WO2002076971A1 (en) * 2001-03-08 2002-10-03 Biocryst Pharmaceuticals, Inc. Compounds useful for inhibiting paramyxovirus neuraminidase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05507068A (ja) * 1990-04-24 1993-10-14 バイオタ、サイアンティフィック、マネージメント、プロプライエタリ、リミテッド ２―デオキシ―２，３―ジデヒドロ―ｎ―アセチルノイラミン酸の誘導体及び類似体と抗ウイルス剤としてのそれらの用途
JPH11279168A (ja) * 1996-07-22 1999-10-12 Sankyo Co Ltd ノイラミン酸誘導体
WO1998011083A1 (en) * 1996-09-10 1998-03-19 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydrosialic acids
WO2002076971A1 (en) * 2001-03-08 2002-10-03 Biocryst Pharmaceuticals, Inc. Compounds useful for inhibiting paramyxovirus neuraminidase

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6014033226; Ｊ．Ｏｒｇ．Ｃｈｅｍ． ６９, 2004, ｐ．６６５-６７９ *
JPN6014033228; Ｊ．Ｃｈｅｍ．Ｉｎｆ．Ｍｏｄｅｌ． ４８, 2008, ｐ．２０７４-２０８０ *
JPN6014033231; Ｎａｔｕｒｅ ４４３, 2006, ４５-４９ *
JPN6014033234; Ｖｉｒｏｌｏｇｙ ５８, 1974, ｐ．４５７-４６３ *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015117233A (ja) * 2013-11-15 2015-06-25 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
JP2018016579A (ja) * 2016-07-27 2018-02-01 国立研究開発法人理化学研究所 シアル酸類縁体

Also Published As

Publication number Publication date
EP2454248A1 (en) 2012-05-23
MX2012000576A (es) 2012-07-20
AU2010273184A1 (en) 2012-03-01
SG177633A1 (en) 2012-02-28
CA2768081A1 (en) 2011-01-20
WO2011006208A1 (en) 2011-01-20
US20120202877A1 (en) 2012-08-09
RU2012105073A (ru) 2013-08-27
AU2010273184B2 (en) 2015-07-09
CN102612514A (zh) 2012-07-25
IL217523A0 (en) 2012-02-29
EP2454248A4 (en) 2013-04-03
CN102612514B (zh) 2016-01-13

Similar Documents

Publication Publication Date Title
JP2012532894A (ja) 抗インフルエンザ薬
US12337007B2 (en) Patentiflorin A analogs as antiviral agents
KR101156273B1 (ko) 황산화 올리고사카라이드 유도체
JP2010285436A (ja) 二量体化合物および抗ウイルス薬としてのそれらの使用
JP2014517032A (ja) 新規のｓｇｌｔ阻害剤
JP2007502778A (ja) 新規スルフェンアミドオキシド
JP2007502779A (ja) 新規スルフェンアミド
WO2013152848A1 (en) Glycomimetics as pseudomonas aeruginosa lectin inhibitors
WO2011000721A1 (en) Inhibitors of microbial infections
JP5616356B2 (ja) モルヒネ−６−グルクロニドの誘導体、これらの調製方法および治療におけるこれらの使用
US20050124559A1 (en) Antimicrobial agent
JP2005531565A (ja) 抗菌剤
CN118005694B (zh) 一种环状核苷类似物及其制备方法和应用
WO2006037185A1 (en) Novel sulfenamides and sulfenamide oxides
US9663548B2 (en) 10-α/β-D-arabinofuranosyl-undecenes as potential anti-mycobacterial agents and process for the preparation thereof
EP3039029B1 (en) Multivalent sialic acid derivates
AU2004266176A1 (en) Novel sulfenamide oxides
AU2003246615A1 (en) An antimicrobial agent
AU2003225343A1 (en) An antimicrobial agent
CA2836661A1 (en) Process for the preparation of compounds useful as inhibitors of sglt-2

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130716

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130716

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140814

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141113

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141120

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141205

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141212

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20150106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150825